Scotiabank raised the firm’s price target on Healthpeak Properties to $23 from $22 and keeps an Outperform rating on the shares. The firm reviewed several key themes from the recent Q1 results and adjusted estimates, the analyst tells investors. U.S. REITS continue to screen historically cheap to the S&P 600, and the firm remains positive on Seniors Housing, Data Centers, and Industrial.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties announces JV wind-down
- Healthpeak Properties upgraded to Outperform from Neutral at Wedbush
- Healthpeak Properties Board Changes and Shareholder Votes
- Healthpeak Properties upgraded at Exane BNP Paribas after guidance boost
- Healthpeak Properties upgraded to Outperform from Neutral at Exane BNP Paribas
